In compliance with the law and its spirit, we aim to make our company one with the trust of the international community.
Enhancing our corporate value through the distribution of safe and high-quality pharmaceutical products and ingredients, we are committed to being a highly professional agent, or in-country caretaker who can contribute to the improvement of people’s health and well-being.
We always intend to respond sincerely to requests of our customers and business partners and provide speedily services that meet the needs of the times with grit and tenacity backed up our expertise, experience, and knowledge.
Please keep your expectation for our ongoing endeavor.
Toshiki Kobayashi, President and CEO
Company Name | Formosa Laboratories Japan Inc. |
---|---|
Head Office | TAKANASHI BLDG. 3F, 2-15-7 NIHONBASHI NINGYO-CHO, CHUO-KU, TOKYO 103-0013, JAPAN(Map) |
Representative | Toshiki KOBAYASHI, President and CEO |
Capital | 10 million yen |
Establishment | February 2019 |
Registration No. of Qualified Invoice Issuer |
T2010001198632 |
Licenses | Pharmaceutical Sales License Pharmaceutical Manufacturing License (Packing, Labeling and Storage) |
Business |
|
Business Partner | FORMOSA LABORATORIES, INC. |
Major Clients | Sawai Pharmaceutical Co., Ltd. TOWA PHARMACEUTICAL CO., LTD. Nichi-Iko Pharmaceutical Co., Ltd. Nipro Pharma Corporation ASKA Pharmaceutical Co., Ltd. Fuji Pharma Co., Ltd. |
Main Banks | Mizuho Bank Ltd., Resona Bank, Limited. Sumitomo Mitsui Banking Corporation, The Bank of Mitsubishi UFJ Ltd., Tokyo City Shinkin Bank |
Membership | Kansai Pharmaceutical Industries Association |
TAKANASHI BLDG. 3F, 2-15-7 NIHONBASHI NINGYO-CHO, CHUO-KU, TOKYO 103-0013, JAPAN
Phone : +81-3-5847-6776
Fax : +81-3-5847-6778
E-mail : info@formosalabjp.com